Clinical TrialsSearch results
Number of results: 929
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients with Neovascular Age-Related Macular Degeneration
- Neovascular Age-related Macular Degeneration (nAMD)
- Takigawa Sotaro
- 2023-10-16
Recruiting
- A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis
- NASH
- Tanigawa Ryohei
- 2023-04-29
Completed
- A Phase 2, Randomized, Double-Blind, does-finding, Parallel Group, Multi-Center Study to evaluate Efficacy and Safety of M118103 in Subjects with Prurigo nodularis.
- Prurigo nodularis
- Nishiura Tomoyuki
- 2021-04-09
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Recruiting
- A Phase 2/3, Open-label, Historical-controlled, Single-arm, Multicenter Studyto Evaluate the Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety ofRavulizumab in Children and Adolescents With Aquaporin-4 Antibody Positive(AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Neuromyelitis Optica Spectrum Disorder
- Wuebbenhorst Hiroaki
- 2022-08-09
Other
- A Phase 3 Study of High dose E0302 against Amyotrophic Lateral Sclerosis - Investigator Initiated Study ("Tsunagi" phase)
- Amyotrophic Lateral Sclerosis
- Endo Akira
- 2024-08-22
Completed
- A Phase 3 Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Hyperphosphatemia Patients on Hemodialysis
- Kinoshita Jun
- 2021-03-04
Other
- A Phase 3 study of S-217622 targeting non-hospitalized participants
- COVID-19
- Portsmouth Simon
- 2022-10-01
Other
- A phase 3 study of S-812217 in combination with an antidepressant in patients with major depressive disorder
- depression
- Gomez Juan Carlos
- 2022-10-28